Skip to main navigation Skip to search Skip to main content

Medicatie aanpassen aan het einde van het leven

  • Eric C. T. Geijteman
  • , Eline E. C. M. Elsten
  • , P. H. M. Hugo van der Kuy
  • , Agnes van der Heide
  • , C. Karin C. D. van der Rijt
  • , Lia van Zuylen
  • Erasmus University Rotterdam
  • Contact: Eric C.T. Geijteman ([email protected]))
  • Afd. Medische Oncologie:

Research output: Contribution to journalArticleProfessional

Abstract

Patients with a limited life expectancy use many medications. Especially medications with a focus on the prevention and treatment of illnesses may be inappropriate in this last phase of life. We present the cases of three patients in which we highlight that such medication reconsideration 1) is quite often done shortly before death, 2) is not without potential disadvantages, and 3) should be accompanied with a patient centered and positive communication style. We argue that the use of medications should be reconsidered in a timely phase, ideally as part of advance care planning.
Original languageDutch
JournalNederlands tijdschrift voor geneeskunde
Volume165
Publication statusPublished - 16 Sept 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this